tci Medicare Compliance & Reimbursement - 2004 Issue 4
Pharmaceuticals: CMS TACKLES AWP
Subscribe or sign in to view the full article.
Article Overview
This article explains a CMS rule update tied to Medicare payment changes for covered drugs and drug administration services. It is relevant to physicians, oncology practices, and medical coders who follow Medicare reimbursement policy, Federal Register updates, and drug payment methodology changes. The article focuses on the general shift in payment percentages, the timing of the rule, and the broader practice-expense adjustment that accompanies it.
Why This Topic Matters
Changes to Medicare drug payment methodology can affect claim reimbursement, practice revenue, and billing workflows for offices that administer injectable and other covered medications.
What You Will Learn
- What CMS changed in Medicare’s payment approach for covered drugs
- How the rule relates to drug administration and practice expense payments
- Why the update matters for physician offices and oncology practices
- What implementation timing and comment-period details were announced
Who Should Read This
- Medical coders
- Billing staff
- Physician practices
- Oncology practices
- Healthcare reimbursement professionals
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com